$253 Million is the total value of Endurant Capital Management LP's 70 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 137.5% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMY | Buy | BRISTOL MYERS SQUIBB CO | $13,897,000 | +441.8% | 291,281 | +490.4% | 5.49% | +305.2% |
IIN | Buy | INTRICON CORP | $13,856,000 | +111.8% | 552,457 | +122.8% | 5.48% | +58.4% |
ICLR | Buy | ICON PLC | $13,777,000 | +159.2% | 100,874 | +145.2% | 5.45% | +93.9% |
VCRA | New | VOCERA COMMUNICATIONS INC | $12,364,000 | – | 390,887 | +100.0% | 4.89% | – |
CI | Sell | CIGNA CORP NEW | $10,774,000 | -20.0% | 66,997 | -5.6% | 4.26% | -40.2% |
SPY | New | SPDR S&P 500 ETF TRput | $10,480,000 | – | 37,100 | +100.0% | 4.14% | – |
GILD | New | GILEAD SCIENCES INC | $10,128,000 | – | 155,793 | +100.0% | 4.00% | – |
ZBH | Sell | ZIMMER BIOMET HLDGS INC | $9,869,000 | -23.2% | 77,286 | -37.6% | 3.90% | -42.6% |
TAK | New | TAKEDA PHARMACEUTICAL CO LTDsponsored ads | $8,911,000 | – | 437,436 | +100.0% | 3.52% | – |
Buy | FLUIDIGM CORP DELnote 2.750% 2/0 | $8,191,000 | +225.4% | 8,756,000 | +218.4% | 3.24% | +143.5% | |
HCA | New | HCA HEALTHCARE INC | $7,833,000 | – | 60,075 | +100.0% | 3.10% | – |
WMGI | Sell | WRIGHT MED GROUP N V | $7,781,000 | +1.3% | 247,417 | -12.3% | 3.08% | -24.2% |
RCM | Sell | R1 RCM INC | $7,256,000 | +2.2% | 750,376 | -16.0% | 2.87% | -23.6% |
ATRC | New | ATRICURE INC | $7,142,000 | – | 266,577 | +100.0% | 2.82% | – |
ABC | Buy | AMERISOURCEBERGEN CORP | $7,040,000 | +1035.5% | 88,536 | +961.6% | 2.78% | +748.5% |
LH | New | LABORATORY CORP AMER HLDGS | $6,864,000 | – | 44,869 | +100.0% | 2.71% | – |
AVDR | New | AVEDRO INC | $5,423,000 | – | 441,989 | +100.0% | 2.14% | – |
EVH | New | EVOLENT HEALTH INCcl a | $5,268,000 | – | 418,728 | +100.0% | 2.08% | – |
LIVN | New | LIVANOVA PLC | $4,115,000 | – | 42,312 | +100.0% | 1.63% | – |
IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $3,773,000 | +201.4% | 50,333 | +179.3% | 1.49% | +125.4% |
XLV | New | SELECT SECTOR SPDR TRput | $3,734,000 | – | 40,700 | +100.0% | 1.48% | – |
THC | New | TENET HEALTHCARE CORP | $3,513,000 | – | 121,823 | +100.0% | 1.39% | – |
ACRS | New | ACLARIS THERAPEUTICS INC | $3,269,000 | – | 545,729 | +100.0% | 1.29% | – |
MDT | Sell | MEDTRONIC PLC | $3,241,000 | -61.6% | 35,579 | -61.7% | 1.28% | -71.3% |
QQQ | New | INVESCO QQQ TRput | $2,982,000 | – | 16,600 | +100.0% | 1.18% | – |
CNC | New | CENTENE CORP DEL | $2,920,000 | – | 54,995 | +100.0% | 1.15% | – |
TMO | New | THERMO FISHER SCIENTIFIC INC | $2,874,000 | – | 10,500 | +100.0% | 1.14% | – |
OCUL | Buy | OCULAR THERAPEUTIX INC | $2,843,000 | +207.0% | 716,124 | +207.7% | 1.12% | +129.9% |
LMNX | New | LUMINEX CORP DEL | $2,785,000 | – | 121,017 | +100.0% | 1.10% | – |
NTGN | New | NEON THERAPEUTICS INC | $2,747,000 | – | 425,291 | +100.0% | 1.09% | – |
LQDA | Buy | LIQUIDIA TECHNOLOGIES INC | $2,678,000 | +215.8% | 235,329 | +501.3% | 1.06% | +136.4% |
AGN | Sell | ALLERGAN PLC | $2,674,000 | -83.2% | 18,263 | -84.7% | 1.06% | -87.4% |
ANTM | New | ANTHEM INC | $2,607,000 | – | 9,084 | +100.0% | 1.03% | – |
BHC | Sell | BAUSCH HEALTH COS INC | $2,577,000 | -14.9% | 104,344 | -36.3% | 1.02% | -36.3% |
VCEL | New | VERICEL CORP | $2,156,000 | – | 123,111 | +100.0% | 0.85% | – |
XENT | New | INTERSECT ENT INC | $2,108,000 | – | 65,557 | +100.0% | 0.83% | – |
KRYS | Buy | KRYSTAL BIOTECH INC | $2,012,000 | +673.8% | 61,155 | +389.2% | 0.80% | +480.3% |
AXGT | New | AXOVANT SCIENCES LTD | $1,933,000 | – | 1,453,314 | +100.0% | 0.76% | – |
ABT | New | ABBOTT LABS | $1,916,000 | – | 23,966 | +100.0% | 0.76% | – |
ALGN | New | ALIGN TECHNOLOGY INC | $1,864,000 | – | 6,557 | +100.0% | 0.74% | – |
MRNS | New | MARINUS PHARMACEUTICALS INC | $1,828,000 | – | 437,299 | +100.0% | 0.72% | – |
VKTX | Buy | VIKING THERAPEUTICS INC | $1,774,000 | +333.7% | 178,448 | +233.8% | 0.70% | +224.5% |
OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $1,768,000 | -70.0% | 102,593 | -77.8% | 0.70% | -77.6% |
ABBV | New | ABBVIE INC | $1,747,000 | – | 21,674 | +100.0% | 0.69% | – |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $1,712,000 | -27.4% | 14,364 | -33.5% | 0.68% | -45.7% |
XRAY | Sell | DENTSPLY SIRONA INC | $1,438,000 | -67.4% | 28,988 | -75.5% | 0.57% | -75.6% |
TVTY | New | TIVITY HEALTH INC | $1,368,000 | – | 77,929 | +100.0% | 0.54% | – |
New | SENSEONICS HLDGS INCnote 5.250% 2/0 | $1,060,000 | – | 1,000,000 | +100.0% | 0.42% | – | |
A | New | AGILENT TECHNOLOGIES INC | $1,011,000 | – | 12,583 | +100.0% | 0.40% | – |
OSMT | Buy | OSMOTICA PHARMACEUTICALS PLC | $1,006,000 | -44.0% | 279,561 | +20.5% | 0.40% | -58.1% |
MOH | New | MOLINA HEALTHCARE INC | $828,000 | – | 5,830 | +100.0% | 0.33% | – |
SIEN | New | SIENTRA INC | $758,000 | – | 88,373 | +100.0% | 0.30% | – |
AXSM | Sell | AXSOME THERAPEUTICS INC | $744,000 | +26.1% | 52,268 | -75.0% | 0.29% | -5.8% |
TDOC | New | TELADOC HEALTH INC | $731,000 | – | 13,153 | +100.0% | 0.29% | – |
VRAY | New | VIEWRAY INC | $714,000 | – | 96,580 | +100.0% | 0.28% | – |
PTCT | New | PTC THERAPEUTICS INC | $636,000 | – | 16,903 | +100.0% | 0.25% | – |
HSIC | New | HENRY SCHEIN INC | $631,000 | – | 10,503 | +100.0% | 0.25% | – |
CVS | Sell | CVS HEALTH CORP | $595,000 | -93.8% | 11,036 | -92.5% | 0.24% | -95.4% |
HAE | New | HAEMONETICS CORP | $585,000 | – | 6,691 | +100.0% | 0.23% | – |
IMGN | New | IMMUNOGEN INC | $500,000 | – | 184,440 | +100.0% | 0.20% | – |
VTGN | New | VISTAGEN THERAPEUTICS INC | $462,000 | – | 360,940 | +100.0% | 0.18% | – |
ANAB | Sell | ANAPTYSBIO INC | $444,000 | -45.3% | 6,082 | -52.2% | 0.18% | -59.0% |
SGRY | New | SURGERY PARTNERS INC | $438,000 | – | 38,805 | +100.0% | 0.17% | – |
ARRY | Sell | ARRAY BIOPHARMA INC | $401,000 | -72.5% | 16,447 | -83.9% | 0.16% | -79.4% |
BHVN | New | BIOHAVEN PHARMACTL HLDG CO L | $385,000 | – | 7,479 | +100.0% | 0.15% | – |
DVAX | New | DYNAVAX TECHNOLOGIES CORP | $302,000 | – | 41,288 | +100.0% | 0.12% | – |
GRTS | New | GRITSTONE ONCOLOGY INC | $283,000 | – | 21,257 | +100.0% | 0.11% | – |
IMGN | New | IMMUNOGEN INCcall | $235,000 | – | 86,800 | +100.0% | 0.09% | – |
ALDX | Sell | ALDEYRA THERAPEUTICS INC | $213,000 | -61.5% | 23,576 | -64.6% | 0.08% | -71.2% |
PTI | New | PROTEOSTASIS THERAPEUTICS INcall | $165,000 | – | 130,600 | +100.0% | 0.06% | – |
MCK | Exit | MCKESSON CORP | $0 | – | -4,966 | -100.0% | -0.29% | – |
FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -58,240 | -100.0% | -0.30% | – |
AXGN | Exit | AXOGEN INC | $0 | – | -39,961 | -100.0% | -0.43% | – |
JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -6,588 | -100.0% | -0.45% | – |
BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -30,560 | -100.0% | -0.57% | – |
TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDsponsored adr | $0 | – | -73,884 | -100.0% | -0.60% | – |
SYK | Exit | STRYKER CORP | $0 | – | -7,319 | -100.0% | -0.61% | – |
ARAY | Exit | ACCURAY INC | $0 | – | -455,018 | -100.0% | -0.82% | – |
PETS | Exit | PETMED EXPRESS INC | $0 | – | -67,010 | -100.0% | -0.82% | – |
FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -236,648 | -100.0% | -1.08% | – |
MYL | Exit | MYLAN N V | $0 | – | -77,135 | -100.0% | -1.12% | – |
NVRO | Exit | NEVRO CORP | $0 | – | -54,977 | -100.0% | -1.13% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -318,185 | -100.0% | -1.49% | – |
PODD | Exit | INSULET CORP | $0 | – | -40,727 | -100.0% | -1.71% | – |
SNY | Exit | SANOFIsponsored adr | $0 | – | -81,401 | -100.0% | -1.87% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -16,732 | -100.0% | -2.20% | – |
EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -85,272 | -100.0% | -2.78% | – |
HOLX | Exit | HOLOGIC INC | $0 | – | -135,805 | -100.0% | -2.95% | – |
MDRX | Exit | ALLSCRIPTS HEALTHCARE SOLUTN | $0 | – | -591,533 | -100.0% | -3.01% | – |
DVA | Exit | DAVITA INC | $0 | – | -140,729 | -100.0% | -3.83% | – |
SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -46,100 | -100.0% | -4.24% | – |
CELG | Exit | CELGENE CORP | $0 | – | -168,609 | -100.0% | -5.71% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
MCKESSON CORP | 27 | Q1 2023 | 4.4% |
CENCORA INC | 26 | Q3 2023 | 5.9% |
HOLOGIC INC | 24 | Q3 2023 | 7.5% |
JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-04-10 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-09-08 |
13F-HR | 2023-08-14 |
3/A | 2023-05-24 |
13F-HR | 2023-05-15 |
3 | 2023-05-15 |
SC 13D | 2023-05-15 |
SC 13G/A | 2023-03-21 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.